The forecasted average length of stay for leiomyoma of the uterus in the UK shows a slight upward trend from 2.6 days in 2024 to 2.8 days in 2028. This indicates an expected increase of approximately 3.8% from 2024 to 2028. Comparatively, there is a consistent increase each year, with the average compound annual growth rate (CAGR) for this period standing at about 1.9% annually.
The length of stay in 2023 stood at approximately 2.6 days, so the forecast indicates a continuation of slight increases. Monitoring future healthcare policies, advancements in medical treatments, and hospital efficiency measures will be crucial in understanding and potentially influencing these trends further.
